Innerspace is an Innsbruck, Austria–based startup that provides software and virtual reality solutions for risk assessment of production processes and standardized cleanroom training for pharmaceutical personnel. Its offerings include a proprietary “Frame-by-Frame Risk Profiling” method and a standardized cleanroom simulator delivered in VR. The company applies psychological insights and innovative technologies to minimize human errors and reduce process risks in pharmaceutical manufacturing. Innerspace serves the pharmaceutical sector and is an official partner of the Parenteral Drug Association (PDA), helping develop and implement industry training courses. The company raised €5.7M to support product development and international expansion. Management plans to use the proceeds to expand its international market presence and further develop its Frame-by-Frame technology. Innerspace develops psychologically based training solutions for critical applications in the life‑science industry using its DeepTraining approach implemented in virtual reality. The platform prepares cleanroom operators for key moments of their work, allowing regular virtual practice to deepen behaviour patterns and understanding of production in critical areas. Innerspace already supplies numerous international pharmaceutical companies with its VR training products. Founded in 2017 and led by CEO Sebastian Scheler, the company is based in Wattens, Innsbruck, Austria. It raised over €1m in growth funding and plans to use the proceeds for global expansion and to double its team to approximately 50 employees.

Total raised

$7M

Funding rounds

2

Latest round

Equity

Latest activity

Feb 2024